[ad_1]
Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world’s second-largest economy, where the appetite for similar treatments is surging.
[ad_1]
Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world’s second-largest economy, where the appetite for similar treatments is surging.
Revolutionizing Tennis Viewing: IBM's AI Technology Enhances Wimbledon Fan Experience
After a pandemic boom, hiring is down for jobs that require a bachelor’s degree. ‘These…
Deutsche Lufthansa cut its guidance for the year, warning it will be increasingly challenging for…
Sign in to your account